Papillary thyroid cancer organoids harboring BRAFV600E mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies
Dong Chen(Bengbu Medical College), Zhao Yong-sheng(Peking University Shenzhen Hospital)
Cited by 45
Related Papers
Organoid Cultures Derived From Patients With Papillary Thyroid Cancer
|The Journal of Clinical Endocrinology & Metabolism|2021|71